Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Neoadjuvant Cetuximab in HNSCC Combined With Curative Surgery
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Chemoradiation Treatment for Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Cetuximab to Treat Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Effect of Cetuximab on Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Irinotecan/Oxaliplatin/5-Fluorouracil/Leucovorin/Cetuximab As First Line Treatment In Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1